The Future of Pharma is Digital: An Evening with Click Therapeutics

​You're invited to an exclusive evening with Click Therapeutics.

​Join us for an intimate gathering of industry leaders to discuss the future of digital medicine over complimentary cocktails and hors d'oeuvres.

​Following Click’s major clinical and regulatory successes this year, including the first successful Phase III trial for any treatment in negative symptoms of schizophrenia, and FDA authorization of the first digital therapeutic for the preventative treatment of episodic migraine, we want to share how our powerful technology engine can be applied to solve challenges across the therapeutic spectrum.

​This isn't just a celebration of specific milestones; it's a look under the hood at the platform that makes addressing previously unmet medical needs possible. We will share insights on Click’s platform and rigorous clinical validation track record.

​Click Therapeutics looks forward to welcoming you for networking amongst peers and a forward-looking discussion on medicine’s next frontier.